According to Alnylam Pharmaceuticals latest financial reports the total liabilities of ALNY is $4.05B, an increase of 9.34% to 2022. At the end of 2022 company had $3.70B total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Alnylam Pharmaceuticals is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $4.05B | 9.34% |
2022 | $3.70B | 21.26% |
2021 | $3.06B | 27.78% |
2020 | $2.39B | 149.97% |
2019 | $956.44M | 840.08% |
2018 | $101.74M | - |